Literature DB >> 4881690

Adrenergic blocking agents. A double-blind trial in the treatment of the eye signs of thyroid disorders.

A L Crombie, A A Lawson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4881690      PMCID: PMC506653          DOI: 10.1136/bjo.52.8.616

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  8 in total

1.  GUANETHIDINE IN HYPERTHYROIDISM.

Authors:  S S WALDSTEIN; G H WEST; W Y LEE; D BRONSKY
Journal:  JAMA       Date:  1964-08-24       Impact factor: 56.272

2.  Effects of oral and intramuscular administration of reserpine in thyrotoxicosis.

Authors:  J J CANARY; M SCHAAF; B J DUFFY; L H KYLE
Journal:  N Engl J Med       Date:  1957-09-05       Impact factor: 91.245

3.  Studies of thyroid and sympathetic nervous system interrelationships. I. The blepharoptosis of myxedema.

Authors:  W Y LEE; P K MORIMOTO; D BRONSKY; S S WALDSTEIN
Journal:  J Clin Endocrinol Metab       Date:  1961-11       Impact factor: 5.958

4.  Guanethidine (Ismelin) in ophthalmology. II. Clinical application in glaucoma.

Authors:  J A OOSTERHUIS
Journal:  Arch Ophthalmol       Date:  1962-06

5.  Adrenergic blockade and the eye signs of thyrotoxicosis.

Authors:  J M Sneddon; P Turner
Journal:  Lancet       Date:  1966-09-03       Impact factor: 79.321

6.  Topical guanethidine therapy for endocrine lid retraction.

Authors:  A J Gay; M A Wolkstein
Journal:  Arch Ophthalmol       Date:  1966-09

7.  Topical sympatholytic therapy for pathologic lid retraction.

Authors:  A J Gay; M L Salmon; M A Wolkstein
Journal:  Arch Ophthalmol       Date:  1967-03

8.  GUANETHIDINE AND PUPILLARY REACTION.

Authors:  W DORIAN; K E SCHIRMER
Journal:  Can Med Assoc J       Date:  1964-04-11       Impact factor: 8.262

  8 in total
  1 in total

Review 1.  Uses of beta-adrenoceptor blocking drugs.

Authors:  B N Prichard; D G McDevitt; R G Shanks
Journal:  J R Coll Physicians Lond       Date:  1976-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.